Modification to the Capsid of the Adenovirus Vector that Enhances Dendritic Cell Infection and Transgene-Specific Cellular Immune Responses

Stefan Worgall, Annette Busch, Michael Rivara, David Bonnyay, Philip L. Leopold, Robert Merritt, Neil R. Hackett, Peter W. Rovelink, Joseph T. Bruder, Thomas J. Wickham, Imi Kovesdi, Ronald Crystal

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Adenovirus (Ad) gene transfer vectors can be used to transfer and express antigens and function as strong adjuvants and thus are useful platforms for the development of genetic vaccines. Based on the hypothesis that Ad vectors with enhanced infectibility of dendritic cells (DC) may be able to evoke enhanced immune responses against antigens encoded by the vector in vivo, the present study analyzes the vaccine potential of an Ad vector expressing β-galactosidase as a model antigen and genetically modified with RGD on the fiber knob [AdZ.F(RGD)] to more selectively infect DC and consequently enhance immunity against the β-galactosidase antigen. Infection of murine DC in vitro with AdZ.F(RGD) showed an eightfold-increased transgene expression following infection compared to AdZ (also expressing β-galactosidase, but with a wild-type capsid). Binding, cellular uptake, and trafficking in DC were also increased with AdZ.F(RGD) compared to AdZ. To determine whether AdZ.F(RGD) could evoke enhanced immune responses to β-galactosidase in vivo, C57BL/6 mice were immunized with AdZ.F(RGD) or AdZ subcutaneously via the footpad. Humoral responses with both vectors were comparable, with similar anti-β-galactosidase antibody levels following vector administration. However, cellular responses to β-galactosidase were significantly enhanced, with the frequency of CD4+ as well as the CD8+ β-galactosidase-specific gamma interferon response in cells isolated from the draining lymph nodes increased following immunization with AdZ.F(RGD) compared to Ad.Z (P < 0.01). Importantly, this enhanced cellular immune response of the AdZ.F(RGD) vector was sufficient to evoke enhanced inhibition of the growth of preexisting tumors expressing β-galactosidase: BALB/c mice implanted with the CT26 syngeneic β-galactosidase-expressing colon carcinoma cell line and subsequently immunized with AdZ.F(RGD) showed decreased tumor growth and improved survival compared to mice immunized with AdZ. These data demonstrate that addition of an RGD motif to the Ad fiber knob increases the infectibility of DC and leads to enhanced cellular immune responses to the Ad-transferred transgene, suggesting that the RGD capsid modification may be useful in developing Ad-based vaccines.

Original languageEnglish
Pages (from-to)2572-2580
Number of pages9
JournalJournal of Virology
Volume78
Issue number5
DOIs
Publication statusPublished - 1 Mar 2004
Externally publishedYes

Fingerprint

Galactosidases
galactosidases
capsid
Capsid
Adenoviridae
dendritic cells
Transgenes
Cellular Immunity
cell-mediated immunity
Dendritic Cells
transgenes
Infection
infection
Adenovirus Vaccines
antigens
mice
vaccines
Antigens
immune response
genetic vectors

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Insect Science
  • Virology

Cite this

Modification to the Capsid of the Adenovirus Vector that Enhances Dendritic Cell Infection and Transgene-Specific Cellular Immune Responses. / Worgall, Stefan; Busch, Annette; Rivara, Michael; Bonnyay, David; Leopold, Philip L.; Merritt, Robert; Hackett, Neil R.; Rovelink, Peter W.; Bruder, Joseph T.; Wickham, Thomas J.; Kovesdi, Imi; Crystal, Ronald.

In: Journal of Virology, Vol. 78, No. 5, 01.03.2004, p. 2572-2580.

Research output: Contribution to journalArticle

Worgall, S, Busch, A, Rivara, M, Bonnyay, D, Leopold, PL, Merritt, R, Hackett, NR, Rovelink, PW, Bruder, JT, Wickham, TJ, Kovesdi, I & Crystal, R 2004, 'Modification to the Capsid of the Adenovirus Vector that Enhances Dendritic Cell Infection and Transgene-Specific Cellular Immune Responses', Journal of Virology, vol. 78, no. 5, pp. 2572-2580. https://doi.org/10.1128/JVI.78.5.2572-2580.2004
Worgall, Stefan ; Busch, Annette ; Rivara, Michael ; Bonnyay, David ; Leopold, Philip L. ; Merritt, Robert ; Hackett, Neil R. ; Rovelink, Peter W. ; Bruder, Joseph T. ; Wickham, Thomas J. ; Kovesdi, Imi ; Crystal, Ronald. / Modification to the Capsid of the Adenovirus Vector that Enhances Dendritic Cell Infection and Transgene-Specific Cellular Immune Responses. In: Journal of Virology. 2004 ; Vol. 78, No. 5. pp. 2572-2580.
@article{a6db898afbcf483bb5865d9256d97832,
title = "Modification to the Capsid of the Adenovirus Vector that Enhances Dendritic Cell Infection and Transgene-Specific Cellular Immune Responses",
abstract = "Adenovirus (Ad) gene transfer vectors can be used to transfer and express antigens and function as strong adjuvants and thus are useful platforms for the development of genetic vaccines. Based on the hypothesis that Ad vectors with enhanced infectibility of dendritic cells (DC) may be able to evoke enhanced immune responses against antigens encoded by the vector in vivo, the present study analyzes the vaccine potential of an Ad vector expressing β-galactosidase as a model antigen and genetically modified with RGD on the fiber knob [AdZ.F(RGD)] to more selectively infect DC and consequently enhance immunity against the β-galactosidase antigen. Infection of murine DC in vitro with AdZ.F(RGD) showed an eightfold-increased transgene expression following infection compared to AdZ (also expressing β-galactosidase, but with a wild-type capsid). Binding, cellular uptake, and trafficking in DC were also increased with AdZ.F(RGD) compared to AdZ. To determine whether AdZ.F(RGD) could evoke enhanced immune responses to β-galactosidase in vivo, C57BL/6 mice were immunized with AdZ.F(RGD) or AdZ subcutaneously via the footpad. Humoral responses with both vectors were comparable, with similar anti-β-galactosidase antibody levels following vector administration. However, cellular responses to β-galactosidase were significantly enhanced, with the frequency of CD4+ as well as the CD8+ β-galactosidase-specific gamma interferon response in cells isolated from the draining lymph nodes increased following immunization with AdZ.F(RGD) compared to Ad.Z (P < 0.01). Importantly, this enhanced cellular immune response of the AdZ.F(RGD) vector was sufficient to evoke enhanced inhibition of the growth of preexisting tumors expressing β-galactosidase: BALB/c mice implanted with the CT26 syngeneic β-galactosidase-expressing colon carcinoma cell line and subsequently immunized with AdZ.F(RGD) showed decreased tumor growth and improved survival compared to mice immunized with AdZ. These data demonstrate that addition of an RGD motif to the Ad fiber knob increases the infectibility of DC and leads to enhanced cellular immune responses to the Ad-transferred transgene, suggesting that the RGD capsid modification may be useful in developing Ad-based vaccines.",
author = "Stefan Worgall and Annette Busch and Michael Rivara and David Bonnyay and Leopold, {Philip L.} and Robert Merritt and Hackett, {Neil R.} and Rovelink, {Peter W.} and Bruder, {Joseph T.} and Wickham, {Thomas J.} and Imi Kovesdi and Ronald Crystal",
year = "2004",
month = "3",
day = "1",
doi = "10.1128/JVI.78.5.2572-2580.2004",
language = "English",
volume = "78",
pages = "2572--2580",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "5",

}

TY - JOUR

T1 - Modification to the Capsid of the Adenovirus Vector that Enhances Dendritic Cell Infection and Transgene-Specific Cellular Immune Responses

AU - Worgall, Stefan

AU - Busch, Annette

AU - Rivara, Michael

AU - Bonnyay, David

AU - Leopold, Philip L.

AU - Merritt, Robert

AU - Hackett, Neil R.

AU - Rovelink, Peter W.

AU - Bruder, Joseph T.

AU - Wickham, Thomas J.

AU - Kovesdi, Imi

AU - Crystal, Ronald

PY - 2004/3/1

Y1 - 2004/3/1

N2 - Adenovirus (Ad) gene transfer vectors can be used to transfer and express antigens and function as strong adjuvants and thus are useful platforms for the development of genetic vaccines. Based on the hypothesis that Ad vectors with enhanced infectibility of dendritic cells (DC) may be able to evoke enhanced immune responses against antigens encoded by the vector in vivo, the present study analyzes the vaccine potential of an Ad vector expressing β-galactosidase as a model antigen and genetically modified with RGD on the fiber knob [AdZ.F(RGD)] to more selectively infect DC and consequently enhance immunity against the β-galactosidase antigen. Infection of murine DC in vitro with AdZ.F(RGD) showed an eightfold-increased transgene expression following infection compared to AdZ (also expressing β-galactosidase, but with a wild-type capsid). Binding, cellular uptake, and trafficking in DC were also increased with AdZ.F(RGD) compared to AdZ. To determine whether AdZ.F(RGD) could evoke enhanced immune responses to β-galactosidase in vivo, C57BL/6 mice were immunized with AdZ.F(RGD) or AdZ subcutaneously via the footpad. Humoral responses with both vectors were comparable, with similar anti-β-galactosidase antibody levels following vector administration. However, cellular responses to β-galactosidase were significantly enhanced, with the frequency of CD4+ as well as the CD8+ β-galactosidase-specific gamma interferon response in cells isolated from the draining lymph nodes increased following immunization with AdZ.F(RGD) compared to Ad.Z (P < 0.01). Importantly, this enhanced cellular immune response of the AdZ.F(RGD) vector was sufficient to evoke enhanced inhibition of the growth of preexisting tumors expressing β-galactosidase: BALB/c mice implanted with the CT26 syngeneic β-galactosidase-expressing colon carcinoma cell line and subsequently immunized with AdZ.F(RGD) showed decreased tumor growth and improved survival compared to mice immunized with AdZ. These data demonstrate that addition of an RGD motif to the Ad fiber knob increases the infectibility of DC and leads to enhanced cellular immune responses to the Ad-transferred transgene, suggesting that the RGD capsid modification may be useful in developing Ad-based vaccines.

AB - Adenovirus (Ad) gene transfer vectors can be used to transfer and express antigens and function as strong adjuvants and thus are useful platforms for the development of genetic vaccines. Based on the hypothesis that Ad vectors with enhanced infectibility of dendritic cells (DC) may be able to evoke enhanced immune responses against antigens encoded by the vector in vivo, the present study analyzes the vaccine potential of an Ad vector expressing β-galactosidase as a model antigen and genetically modified with RGD on the fiber knob [AdZ.F(RGD)] to more selectively infect DC and consequently enhance immunity against the β-galactosidase antigen. Infection of murine DC in vitro with AdZ.F(RGD) showed an eightfold-increased transgene expression following infection compared to AdZ (also expressing β-galactosidase, but with a wild-type capsid). Binding, cellular uptake, and trafficking in DC were also increased with AdZ.F(RGD) compared to AdZ. To determine whether AdZ.F(RGD) could evoke enhanced immune responses to β-galactosidase in vivo, C57BL/6 mice were immunized with AdZ.F(RGD) or AdZ subcutaneously via the footpad. Humoral responses with both vectors were comparable, with similar anti-β-galactosidase antibody levels following vector administration. However, cellular responses to β-galactosidase were significantly enhanced, with the frequency of CD4+ as well as the CD8+ β-galactosidase-specific gamma interferon response in cells isolated from the draining lymph nodes increased following immunization with AdZ.F(RGD) compared to Ad.Z (P < 0.01). Importantly, this enhanced cellular immune response of the AdZ.F(RGD) vector was sufficient to evoke enhanced inhibition of the growth of preexisting tumors expressing β-galactosidase: BALB/c mice implanted with the CT26 syngeneic β-galactosidase-expressing colon carcinoma cell line and subsequently immunized with AdZ.F(RGD) showed decreased tumor growth and improved survival compared to mice immunized with AdZ. These data demonstrate that addition of an RGD motif to the Ad fiber knob increases the infectibility of DC and leads to enhanced cellular immune responses to the Ad-transferred transgene, suggesting that the RGD capsid modification may be useful in developing Ad-based vaccines.

UR - http://www.scopus.com/inward/record.url?scp=10744232251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744232251&partnerID=8YFLogxK

U2 - 10.1128/JVI.78.5.2572-2580.2004

DO - 10.1128/JVI.78.5.2572-2580.2004

M3 - Article

C2 - 14963160

AN - SCOPUS:10744232251

VL - 78

SP - 2572

EP - 2580

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 5

ER -